


Biotech and BNB treasury firm Windtree Therapeutics fell 77% on Wednesday after informing the SEC that it would be delisted from the Nasdaq stock exchange.
When you subscribe to the blog, we will send you an e-mail when there are new updates on the site so you wouldn't miss them.
